|
|
| | 5-OAHSA-d17 Basic information |
| Product Name: | 5-OAHSA-d17 | | Synonyms: | 5-OAHSA-d17;5-(oleoyloxy-11,11',12,12',13,13',14,14',15,15',16,16',17,17',18,18,18-d17)octadecanoicacid | | CAS: | 2714169-20-5 | | MF: | C36H51D17O4 | | MW: | 582.027470226 | | EINECS: | | | Product Categories: | | | Mol File: | 2714169-20-5.mol |  |
| | 5-OAHSA-d17 Chemical Properties |
| solubility | DMF: 20 mg/ml
DMSO: 15 mg/ml
Ethanol: 20 mg/ml
Ethanol: PBS (pH 7.2) (1:1): 0.5 mg/ml |
| | 5-OAHSA-d17 Usage And Synthesis |
| Uses | (E)-5-OAHSA-d17 is deuterium labeled (E)-5-OAHSA[1]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] MARK M YORE. Discovery of a class of endogenous mammalian lipids with anti-diabetic and anti-inflammatory effects.[J]. Cell, 2014, 159 2: 318-332. DOI: 10.1016/j.cell.2014.09.035 |
| | 5-OAHSA-d17 Preparation Products And Raw materials |
|